The Biotech Growth Trust (BIOG) Share Price, News & Analysis

Company Overview

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Key Stats

• Today's Range: 720.60 to 740
• 50-Day Range: 620 to 844
• 52-Week Range: 612.70 to 1,068.36
• Volume: 105,158 shs
• Average Volume: 199,068 shs
• Market Capitalization: £209.69 million
• P/E Ratio: 2.46
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIOG Stock Analysis - Frequently Asked Questions

How have BIOG shares performed this year?

The Biotech Growth Trust's stock was trading at GBX 855 on January 1st, 2025. Since then, BIOG shares have decreased by 14.2% and is now trading at GBX 734.
View the best growth stocks for 2025 here.

How were The Biotech Growth Trust's earnings last quarter?

The Biotech Growth Trust PLC (LON:BIOG) posted its quarterly earnings results on Wednesday, November, 27th. The company reported $0.20 earnings per share (EPS) for the quarter. The Biotech Growth Trust had a net margin of 95.33% and a trailing twelve-month return on equity of 26.96%.

How do I buy shares of The Biotech Growth Trust?

Shares of BIOG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of The Biotech Growth Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that The Biotech Growth Trust investors own include Polar Capital Technology Trust (PCT), Guild Esports (GILD), National Grid (NG.L), Solid Biosciences (SLDB), Scottish Mortgage (SMT), Touchstone Exploration (TXP) and Wheaton Precious Metals (WPM).

Company Calendar

• Last Earnings: 11/27/2024
• Today: 4/25/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:BIOG
• CIK: N/A
• Web: www.biotechgt.com
• Phone: +44-20-74264000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 297.87
• Trailing P/E Ratio: 2.46
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £83.83 million
• Net Margins: 95.33%
• Pretax Margin: N/A
• Return on Equity: 26.96%
• Return on Assets: 12.39%

Debt

• Debt-to-Equity Ratio: 11.02
• Current Ratio: 0.59
• Quick Ratio: 0.00

Sales & Book Value

• Annual Sales: £87.94 million
• Price / Sales: 2.38
• Cash Flow: GBX 8.37 per share
• Price / Cash Flow: 87.74
• Book Value: GBX 1,077.42 per share
• Price / Book: 0.68

Miscellaneous

• Outstanding Shares: 28,568,747
• Free Float: N/A
• Market Cap: £209.69 million
• Optionable: Not Optionable
• Beta: 0.50